Innovision GmbH recently announced the launch of its new 3-D ultrasonic holography technology, a non-invasive technology that allows devices to be equipped for ultrasound of the abdomen, joints or breasts.

Breast cancer death rates among women decreased during 2010-2014, but racial differences persisted, according to a study by the Centers for Disease Control and Prevention (CDC) in this week’s Morbidity and Mortality Weekly Report.

October 14, 2016 — Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its S4-1 cardiac transducer for Lumify, its smart-device diagnostic ultrasound solution.

HHS, Health and Human Services, MACRA, Quality Payment Program, Medicare physician payment

The Department of Health & Human Services (HHS) today finalized a landmark new payment system for Medicare clinicians that will continue the administration’s progress in reforming how the healthcare system pays for care. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Quality Payment Program, which replaces the flawed Sustainable Growth Rate (SGR), will equip clinicians with the tools and flexibility to provide high-quality, patient-centered care.

Researchers at Houston Methodist have developed an artificial intelligence (AI) software that reliably interprets mammograms, assisting doctors with a quick and accurate prediction of breast cancer risk. According to a new study published online Aug. 29 in Cancer, the computer software intuitively translates patient charts into diagnostic information at 30 times human speed and with 99 percent accuracy.

At the 58th annual meeting of the American Society for Radiation Oncology (ASTRO), Orfit Industries presented the new generation of nano-based masks.

Cubresa Inc. recently announced the successful installation of their compact positron emission tomography (PET) scanner called NuPET for preclinical PET and magnetic resonance imaging (MRI) in the Department of Medical Imaging at the University of Arizona (UA).

In the largest trial conducted for average risk (A-R) medulloblastoma, survival rates following reduced radiation therapy (RT) boost volumes were comparable to standard treatment volumes for the primary tumor site. However, lower doses of craniospinal axis irradiation were associated with higher event rates and worse survival, according to research presented at the 58th annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.

eRAD announced that it has added a new product to its comprehensive suite of imaging workflow solutions. RADAR Nudge is a bi-directional, secure collaborative messaging tool for communicating patient information among remote healthcare providers.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now